{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T01:00:55Z","timestamp":1775782855488,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biopha.2025.118640","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:31:34Z","timestamp":1760146294000},"page":"118640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The three dicaffeoylquinic acids of Erigeron breviscapus strengthen anticoagulation of warfarin in rats: Implications in pharmacokinetics and pharmacodynamics"],"prefix":"10.1016","volume":"192","author":[{"given":"Yue","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengnan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuepeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunjuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaofeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118640_bib1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1389200224666230116113240","article-title":"Herb-Drug interactions and their impact on pharmacokinetics: an update","volume":"24","author":"Cheng","year":"2023","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.biopha.2025.118640_bib2","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2174\/1386207323999201110192942","article-title":"Herbal Medicine: clinical perspective and regulatory status","volume":"24","author":"Barkat","year":"2021","journal-title":"Comb. Chem. High. Throughput Screen"},{"key":"10.1016\/j.biopha.2025.118640_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1395698","article-title":"A review of the WHO strategy on traditional, complementary, and integrative Medicine from the perspective of academic consortia for integrative Medicine and health","volume":"11","author":"Hoenders","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.biopha.2025.118640_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153753","article-title":"Herbs and their bioactive ingredients in cardio-protection: underlying molecular mechanisms and evidences from clinical studies","volume":"92","author":"Kumar","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2025.118640_bib5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.38212\/2224-6614.3428","article-title":"Real-world evidence of the Herb-drug interactions","volume":"30","author":"Pan","year":"2022","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.biopha.2025.118640_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116156","article-title":"Herb-drug interactions between panax notoginseng or its biologically active compounds and therapeutic drugs: a comprehensive pharmacodynamic and pharmacokinetic review","volume":"307","author":"Xie","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2025.118640_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154247","article-title":"Real-world data on herb-drug interactions in oncology: a scoping review of pharmacoepidemiological studies","volume":"103","author":"Lam","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2025.118640_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154696","article-title":"Herb-drug interaction of xingnaojing injection and edaravone via pharmacokinetics, mixed inhibition of UGTs, and molecular docking","volume":"112","author":"Qi","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2025.118640_bib9","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/ptr.6585","article-title":"Herb-drug interaction studies of herbs used in treatment of cardiovascular disorders-A narrative review of preclinical and clinical studies","volume":"34","author":"Shaikh","year":"2020","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2025.118640_bib10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s11910-022-01230-6","article-title":"Cerebrovascular disease, cardiovascular disease, and chronic kidney disease: interplays and influences","volume":"22","author":"Spence","year":"2022","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.biopha.2025.118640_bib11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/pharmaceutics13050610","article-title":"Pharmacokinetic Drug-Drug interactions and Herb-Drug interactions","volume":"13","author":"Choi","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2025.118640_bib12","article-title":"The Chinese herb styrax triggers pharmacokinetic herb-drug interactions via inhibiting intestinal CYP3A","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2025.118640_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/0113892002290846240228061506","article-title":"Safety issues of Herb-Warfarin interactions","volume":"25","author":"Hazra","year":"2024","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.biopha.2025.118640_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112103","article-title":"Mechanisms and interactions in concomitant use of herbs and warfarin therapy: an updated review","volume":"143","author":"Leite","year":"2021","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118640_bib15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/bcp.14404","article-title":"Warfarin and food, herbal or dietary supplement interactions: a systematic review","volume":"87","author":"Tan","year":"2021","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2025.118640_bib16","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.118640_bib17","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19","volume":"23","author":"Farge","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2025.118640_bib18","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jacc.2023.05.061","article-title":"ACC\/AHA and ESC\/EACTS guidelines for the management of valvular heart diseases: JACC guideline comparison","volume":"82","author":"Coisne","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2025.118640_bib19","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2025.118640_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40780-023-00282-1","article-title":"Drug interactions between ALK inhibitors and warfarin with concurrent use of bucolome: a case report","volume":"9","author":"Kato","year":"2023","journal-title":"J. Pharm. Health Care Sci."},{"key":"10.1016\/j.biopha.2025.118640_bib21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/bcp.13157","article-title":"Theory-based pharmacokinetics and pharmacodynamics of S- and R-warfarin and effects on international normalized ratio: influence of body size, composition and genotype in cardiac surgery patients","volume":"83","author":"Xue","year":"2017","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2025.118640_bib22","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1055\/s-0039-1696982","article-title":"Warfarin therapy and improved anticoagulation control by patient Self-Management","volume":"119","author":"Ritchie","year":"2019","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.biopha.2025.118640_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/FPC.0000000000000526","article-title":"Association between CYP2C9 and VKORC1 genetic polymorphisms and efficacy and safety of warfarin in Chinese patients","volume":"34","author":"Zhang","year":"2024","journal-title":"Pharm. Genom."},{"key":"10.1016\/j.biopha.2025.118640_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2021.758290","article-title":"Complete chloroplast genome sequence of erigeron breviscapus and characterization of chloroplast regulatory elements","volume":"12","author":"Yu","year":"2021","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.biopha.2025.118640_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep.32221","article-title":"Breviscapine alleviates NASH by inhibiting TGF-beta-activated kinase 1-dependent signaling","volume":"76","author":"Lan","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2025.118640_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154167","article-title":"Petasites japonicus extract exerts anti-malarial effects by inhibiting platelet activation","volume":"102","author":"Yun","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2025.118640_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.114988","article-title":"Dengzhan xixin injection derived from a traditional Chinese herb erigeron breviscapus ameliorates cerebral ischemia\/reperfusion injury in rats via modulation of mitophagy and mitochondrial apoptosis","volume":"288","author":"Yang","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2025.118640_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/1389200221666201217093255","article-title":"Metabolism and pharmacological mechanisms of active ingredients in erigeron breviscapus","volume":"22","author":"Fan","year":"2021","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.biopha.2025.118640_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12906-024-04389-2","article-title":"Effects of sodium ferulate for injection on anticoagulation of warfarin in rats in vivo","volume":"24","author":"Zhao","year":"2024","journal-title":"BMC Complement Med. Ther."},{"key":"10.1016\/j.biopha.2025.118640_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/00498254.2024.2326987","article-title":"Safflower yellow for injection enhances anti-coagulation of warfarin in rats: implications in pharmacodynamics and pharmacokinetics","volume":"54","author":"Liu","year":"2024","journal-title":"Xenobiotica"},{"key":"10.1016\/j.biopha.2025.118640_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108728","article-title":"A comprehensive review on pharmacokinetic mechanism of herb-herb\/drug interactions in Chinese herbal formula","volume":"264","author":"Li","year":"2024","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.biopha.2025.118640_bib32","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2215\/CJN.14021021","article-title":"Apixaban versus warfarin for treatment of venous thromboembolism in patients receiving Long-Term dialysis","volume":"17","author":"Wetmore","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2025.118640_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/jebm.12235","article-title":"Antithrombotic medications in dialysis patients: a double-edged sword","volume":"10","author":"Vlachopanos","year":"2017","journal-title":"J. Evid. Based Med."},{"key":"10.1016\/j.biopha.2025.118640_bib34","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/CIRCULATIONAHA.118.037091","article-title":"Long-Term anticoagulation for patients receiving dialysis","volume":"138","author":"Nigwekar","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.118640_bib35","article-title":"A physiologically based pharmacokinetic\/pharmacodynamic modeling approach for drug-drug interaction evaluation of warfarin enantiomers with sorafenib","volume":"39","author":"Wang","year":"2021","journal-title":"Drug Metab. Pharm."},{"key":"10.1016\/j.biopha.2025.118640_bib36","first-page":"695","article-title":"Identification of human cytochrome P450 and UGT enzymes involved in the metabolism of ferulic acid, a major bioactive component in traditional Chinese medicines","volume":"15","author":"Zhuang","year":"2017","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.biopha.2025.118640_bib37","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2174\/1874467215666220823123852","article-title":"Scutellarin mediates cytochrome P450 3A4 and 2C19 expression via pregnane x receptor and constitutive androstane receptor","volume":"16","author":"Huang","year":"2023","journal-title":"Curr. Mol. Pharm."},{"key":"10.1016\/j.biopha.2025.118640_bib38","first-page":"865","article-title":"Isochlorogenic acid a affects P450 and UGT enzymes in vitro and in vivo","volume":"14","author":"Wang","year":"2016","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.biopha.2025.118640_bib39","first-page":"91","article-title":"Research progress on plasma protein binding rates of active ingredients of traditional Chinese Medicine and discussion on related regularities","volume":"20","author":"Sun","year":"2017","journal-title":"PPCR"},{"issue":"45","key":"10.1016\/j.biopha.2025.118640_bib40","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the european association for Cardio-Thoracic surgery (EACTS)","author":"Van Gelder","year":"2024","journal-title":"Eur. Heart J."},{"issue":"83","key":"10.1016\/j.biopha.2025.118640_bib41","first-page":"109","article-title":"ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines","volume":"2024","author":"Writing Committee","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2025.118640_bib42","first-page":"e545","article-title":"Antithrombotic therapy for VTE disease: second update of","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest Guidel. Expert Panel Report. Chest"},{"key":"10.1016\/j.biopha.2025.118640_bib43","article-title":"Y.X. An integration strategy combined progressive multivariate statistics with anticoagulant activity evaluation for screening anticoagulant quality markers in Chinese patent Medicine","volume":"287","author":"Cui","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2025.118640_bib44","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1248\/bpb.30.935","article-title":"The anti-thrombotic active constituents from centella asiatica","volume":"30","author":"Satake","year":"2007","journal-title":"Biol. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.biopha.2025.118640_bib45","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/bcpt.13531","article-title":"Effects of herba erigerontis injection on pharmacodynamics and pharmacokinetics of warfarin in rats in vivo","volume":"128","author":"Jiang","year":"2021","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2025.118640_bib46","article-title":"Advances in chemical constituents, clinical applications, pharmacology, pharmacokinetics and toxicology of erigeron breviscapus","volume":"12","author":"Wu","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118640_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118462","article-title":"In vivo and in vitro anti-inflammation of rhapontici radix extract on mastitis via TMEM59 and GPR161","volume":"333","author":"Lv","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2025.118640_bib48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13020-020-00376-0","article-title":"Characterization of thrombin\/factor xa inhibitors in rhizoma chuanxiong through UPLC-MS-based multivariate statistical analysis","volume":"15","author":"Yang","year":"2020","journal-title":"Chin. Med."},{"key":"10.1016\/j.biopha.2025.118640_bib49","first-page":"17","article-title":"Determination of isochlorogenic acid a and isochlorogenic acid b in \u201cZhuangyao\u201d yixue'an granules by high performance liquid chromatography","volume":"5","author":"Wei","year":"2024","journal-title":"MSCI"},{"issue":"10","key":"10.1016\/j.biopha.2025.118640_bib50","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1007\/s12011-021-03036-y","article-title":"The effect of serum magnesium level on stable anticoagulation in patients using warfarin for various cardiac indications","volume":"200","author":"Ardahanli","year":"2022","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.biopha.2025.118640_bib51","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjcard.2025.03.015","article-title":"Precision risk stratification in atrial fibrillation: evaluating machine learning models for bleeding prediction and clinical integration","volume":"246","author":"Akg\u00fcn","year":"2025","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.biopha.2025.118640_bib52","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.suc.2022.01.007","article-title":"Epidemiology of coronary artery disease","volume":"102","author":"Duggan","year":"2022","journal-title":"Surg. Clin. North Am."},{"key":"10.1016\/j.biopha.2025.118640_bib53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tcm.2022.09.006","article-title":"The relationship between atrial fibrillation and coronary artery disease: understanding common denominators","volume":"34","author":"Mekhael","year":"2024","journal-title":"Trends Cardiovasc Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:42:28Z","timestamp":1775781748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225008340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":53,"alternative-id":["S0753332225008340"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118640","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The three dicaffeoylquinic acids of Erigeron breviscapus strengthen anticoagulation of warfarin in rats: Implications in pharmacokinetics and pharmacodynamics","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118640"}}